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The aim of these studies was to assess residual virulence and early protec-
tive capacity of a negatively markered live attenuated vaccine candidate Salmo-
nella Enteritidis mutant against a highly virulent S. Enteritidis strain using a day-
old chicken model. Nonflagellated FliD negative mutants of Salmonella Enteriti-
dis 11 (SE11) with and without the virulence plasmid proved to be sufficiently at-
tenuated (limited invasiveness in vitro/in vivo) without reduced ability to colonise 
chicken gut. The early protective activity of a nonflagellated, virulence-plasmid-
cured (fliD–, pSEV∆) mutant against organ invasion, caecal colonisation and fae-
cal shedding by the highly virulent challenge strain S. Enteritidis 147 NalR proved 
to be effective and safe. The innate and adaptive immunity was demonstrable dur-
ing the first four weeks of life, and the serological response was clearly distin-
guishable from the response induced by the wild parental strain. In conclusion, we 
provided data for the first time about a virulence-plasmid-cured, nonflagellated 
mutant of S. Enteritidis to serve as a basis for development of a negatively mark-
ered potential live oral vaccine against virulent S. Enteritidis in chicken. 
Key words: Salmonella Enteritidis, fliD flagellin, vaccine, virulence plasmid, 
chicken  
Poultry products contaminated with Salmonella are a major cause of food-
borne zoonoses, and certain non-host-restricted serovars like Salmonella enterica 
subspecies enterica serovar Enteritidis (S. Enteritidis) have become a worldwide 
public health concern, arising primarily from poultry and eggs (Rodrigue et al., 
1990; EFSA, 2010). This worldwide veterinary public health problem has led to 
an increasing demand for effective vaccines to control S. Enteritidis infection in 
the poultry industry. Vaccination has been recognised as an important preventive 
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measure against salmonellosis of poultry, for which killed parenteral and orally 
applicable live attenuated vaccines have been widely used, as reviewed by Bar-
row (2007) and Van Immerseel et al. (2005). Killed vaccines confer strong pro-
tection primarily against host-restricted Salmonella serovars such as S. Gallina-
rum in poultry (Barrow and Wallis, 2000) but also against the in ovo transmis-
sion of S. Enteritidis (EFSA, 2007). This is probably due to the fact that killed 
vaccines induce good humoral immune responses which may be sufficient 
against septicaemia and related clinical disease. However, antigens present in 
killed vaccines could be more rapidly eliminated from the host as compared to 
live bacteria in orally applied vaccines without effectively stimulating cytotoxic 
T cells, especially in unprimed hosts (Nagaraja and Rajashekara, 1999). These 
facts may explain why the use of killed Salmonella vaccines against non-host-
restricted Salmonella serovars like S. Enteritidis had varying success in poultry 
(Barrow, 2007). Live attenuated Salmonella vaccines have several advantages 
over killed vaccines. They effectively stimulate both cell-mediated and humoral 
immune responses and express appropriate protective antigens in vivo (Van Im-
merseel et al., 2005). Live vaccines have been shown to be more effective in in-
ducing lymphocyte proliferation in response to S. Enteritidis antigens (Babu et 
al., 2003). Furthermore, in the case of oral application on the first day of life the 
newly designed live Salmonella vaccine candidate strains may also protect birds 
by inhibiting colonisation by wild Salmonella strains at a very young age (Bar-
row et al., 1987; Nógrády et al., 2003; Methner et al., 2011a). 
Although experimental data related to the recently developed and mar-
keted vaccines against Salmonella in poultry are generally favourable (Barrow, 
2007; EFSA, 2004, 2007), there are differing regulations for the use of ‘live’ ver-
sus ‘killed’ vaccines in different countries, indicating that there are still several 
aspects to be considered for the further development of such vaccines. One of 
them is the need for serological markers, so that naturally infected and vacci-
nated flocks could be distinguished by simple serological assays. For that pur-
pose, three recent studies have reported the use of nonflagellated fliC (H1 flagel-
lin) deletion mutants of S. Enteritidis (Adriaensen et al., 2007; Methner et al., 
2011b; Matulova et al., 2013), produced by the method reported by Datsenko and 
Wanner (2000). None of these fliC–, nonmotile vaccine candidates were reported 
to be devoid of the S. Enteritidis virulence plasmid. 
Earlier we produced nonflagellated (fliD–) and plasmidless mutants of 
strain S. Enteritidis 11 (Imre et al., 2006, 2011). Here we aimed to test the non-
flagellated (fliD–) mutants of S. Enteritidis 11 with and without the virulence-
plasmid (pSEV) for in vitro and in vivo verification of the attenuation. We also 
aimed to test the ability of a double-attenuated (fliD–, pSEVΔ) strain to protect 
very young chicks against intestinal colonisation and organ invasion by a highly 
virulent S. Enteritidis challenge strain and to prove that the lack of flagellin of 
the fliD– mutant could be utilised as a negative serological marker. 
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Materials and methods 
Bacterial strains 
Salmonella Enteritidis 11 (SE11) PT1 is a wild-type strain isolated from 
poultry and designated as E296 in an earlier study on flagellar systems (Imre et al., 
2005). Its spontaneous nalidixic-acid-resistant derivative (SE11 NalR) was used 
for invasion and colonisation tests. Its spontaneous spectinomycin-resistant de-
rivative (SE11 SpeR) was used for the early protection experiments reported here. 
The two mutants of SE11 used here were as follow: S. Enteritidis 2102 (SE2102) 
a nonmotile, FliD-negative (fliD:pFOL1069), chloramphenicol-resistant mutant 
containing a 55 kb virulence plasmid, and its nonmotile virulence plasmid cured 
(fliD–, pSEVΔ) derivative of SE2102 (SEΔ155) (Imre et al., 2006, 2007, 2011). 
Salmonella Enteritidis 147 NalR (SE147) PT4, a wild-type virulent reference 
strain with a high capability to colonise the intestine and internal organs of day-
old chicks, was used for challenge in protection experiments as described (Meth-
ner et al., 1995). Escherichia coli C600 (Sambrook et al., 1989) served as nega-
tive control in testing in vitro invasion. All strains used here were proven to be 
sensitive to kanamycin (Table 1). 
Table 1 
Organ invasion and caecal colonisation by S. Enteritidis 11 and its nonmotile mutant SE2102 and 
by the nonmotile-plasmidless mutant SEΔ155 in day-old White Leghorn chicks, five days after oral 
inoculation in two independent experiments (A and B) 
Strains used for inocula-
tion and experimental 
groups 
Exp. Infective dose(log10 CFU/chick)
Caecal  
colonisation 
(log10 CFU/g) 
Liver  
invasion 
(+/tested) 
Spleen  
invasion 
(+/tested) 
S. Enteritidis 11 wt A 7.44 6.3 6/6 6/6 
 B 8.39 8.5 6/6 6/6 
S. Enteritidis 2102* A 7.34 5.7 2/6 1/6 
 B 8.17 7.8 3/6 5/6 
S. Enteritidis Δ155** A 7.53 7.0 3/6 2/6 
 B 8.43 8.2 6/6 3/6 
Intact control A Not infected Not applicable 0/4 0/4 
 B   0/4 0/4 
*nonmotile mutant of S. Enteritidis 11 NalR; **nonmotile-plasmidless mutants of S. Enteritidis 11: 
SE2012 (fliD–: CmR) and SEΔ155 (fliD–, pSEVΔ: CmR). Statistically significant (P < 0.05 – P < 
0.001) differences were detected between the wild-type parent strain SE11 and either of the two 
mutants SE2102 and SEΔ155, respectively, regarding organ invasion. No statistically significant 
difference was detectable between mutants SE2102 (fliD–) and SEΔ155 (fliD–, pSEVΔ) regarding 
organ invasion, and no statistically significant difference was detectable between any of the strains 
regarding caecal colonisation 
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Microbiological techniques 
For culturing bacteria the following media (Merck) were used: trypticase 
soy broth (TSB) for general purposes, bromothymol blue–lactose (BTB) agar for 
invasion, colonisation and protection assays, and Rappaport-Vassiliadis (RV) broth 
for the selective enrichment of Salmonella. Antibiotics (Sigma-Aldrich) were 
used in the following final concentrations: chloramphenicol (Cm): 20 μg/ml, 
nalidixic acid (Nal): 50 μg/ml, spectinomycin (Spe): 50 μg/ml, and kanamycin 
(Km): 250 μg/ml. 
In vitro fibroblast invasion 
Primary chicken embryo fibroblasts (CEFs) were obtained from 12-day-
old specific pathogen free (SPF) embryos of the Leghorn breed. CEFs were cul-
tured in MEM (Sigma-Aldrich) complemented with 5% fetal calf serum (FCS). 
One day prior to infection, fibroblasts were seeded into 36-mm Petri dishes (Nunc) 
and grown overnight at 37 °C under 5% CO2. 
The invasiveness of the Salmonella strains was tested as described by Bar-
row and Lovell (1989). Briefly, semi-confluent cell cultures were washed three 
times with PBS and cultivated in DMEM (Sigma-Aldrich) supplemented with 
5% FCS and 1% D-mannose. Overnight bacterial cultures were incubated with 
fibroblasts at 1:200 dilutions for 2 h at 37 °C under 5% CO2. The infectious dose 
was 4–6 × 106 CFU/ml. The number of bacteria in the supernatant was deter-
mined by plating serial dilutions on Bromothymol Blue (BTB) agar plates. CEFs 
were washed three times with PBS and incubated for 1.5 h at 37 °C and 5% CO2 
in MEM (Sigma-Aldrich) containing kanamycin 250 μg/ml to eliminate extracel-
lular bacteria. Finally, cells were washed three times with PBS and digested with 
0.025% trypsin (Sigma-Aldrich) and 1% Tween 20 (Sigma-Aldrich) in 0.01M 
NaH2PO4 (pH 8) for 30 min at 37 °C. Intracellular Salmonella counts were de-
termined by plating serial dilutions on BTB plates. Salmonella invasion was tested 
three times, with 2–3 replicates each time. 
In vivo organ invasion and intestinal colonisation studies 
Specific pathogen free (SPF), day-old White-Leghorn chickens of mixed 
sex (Dabas Hatchery, Hungary) were housed in a room in well-distanced plastic 
boxes (six chickens/box forming one group). In the three experimental groups, 
birds were inoculated by the oral route using a sterile plastic gavage on the day 
of hatch with 0.5 ml of the 20 times diluted stationary-phase TSB culture of S. 
Enteritidis 11 NalR or with one of its two mutants: SE2012 (fliD–: CmR) or 
SEΔ155 (fliD–, pSVEΔ: CmR). Five days after inoculation, chickens from each 
group were killed humanely and 0.2 g of the caecal contents as well as of the 
liver and spleen were removed aseptically from each bird. Caecal content was re-
suspended in a ratio of 1:10 in RV broth containing nalidixic acid in the case of 
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the SE11-inoculated group, or chloramphenicol in the case of chicks inoculated 
with the mutants. From these homogenates, decimal dilutions were made and 
10 μl from each dilution were plated onto BTB agar plates supplemented with 
one or the other of the above antibiotics in order to determine the Salmonella 
CFU/g in the caecal contents. Liver and spleen samples were incubated for 48 h 
at 41 °C in 1.8 ml RV broth containing either nalidixic acid (for isolation of the 
parent SE11) or chloramphenicol (for isolation of the mutants), from which BTB 
plates containing one or the other of the appropriate antibiotics were inoculated 
by loops to determine the presence of Salmonella in the parenchymal organs. The 
experiment was performed twice using a lower dose (approx. 5 × 107 CFU/chick) 
(Experiment A) and a higher dose (approx. 5 × 108 CFU/chick) (Experiment B) 
in order to study the dose response. The noninfected control groups were kept in 
a separate room in complete isolation. The Salmonella-free status of these con-
trol birds was monitored through parallel testing of the caecal content of all 6 
chicks on the 5th day after arrival (ISO 6579). The license for the above patho-
genicity testing and for the assessment of early protection was granted by the 
Animal Health and Food Control Station of Capital Budapest (No. 273/003/2004). 
Assessment of early protection of day-old chicks against S. Enteritidis challenge 
One-day-old Salmonella-free male Ross 308 broiler breeder grandparent 
chickens (Bábolna Hatchery, Hungary) were randomly divided into 6 groups of 
40 chickens/group in two independent experiments. Groups of chickens were 
placed into separate isolation rooms. The chickens were fed an antibiotic-free 
‘finisher’ feed previously tested for the absence of Salmonella (ISO 6579) and of 
the antimicrobial compounds (Ács and Simonffy, 1984). Feed and drinking water 
were made available ad libitum. The animal work was organised so as to prevent 
cross contamination. 
Inoculations were done on the day of hatch (day 1) as follows. One-day-
old birds in the groups ‘Principal 1’ and ‘Principal 2’ were vaccinated by an oral 
gavage with S. Enteritidis 11 (SpeR) or with its nonmotile-plasmidless (fliD–, 
pSEVΔ: CmR) mutant (SEΔ155), respectively, in a dose of approx. 1 × 108 CFU/ 
chick. Both groups were challenged 24 h later with virulent S. Enteritidis 147 
(NalR) by oral gavage with a 1000 times diluted overnight TSB culture (approx. 
1 × 105 CFU/chick). The challenge control group was only inoculated with chal-
lenge strain SE147 (NalR) (approx. 1 × 105 CFU/chick) at one day of age. As a 
safety control, a ‘vaccine control group 1’ and a ‘vaccine control group 2’ were 
inoculated with SE11 (SpeR) or SEΔ155 (fliD–, pSEVΔ: CmR) respectively at 
one day of age in a dose of approx. 1 × 108 CFU/chicken, enabling verification of 
the attenuation level. Birds were inoculated individually by oral gavage. A non-
infected intact control group was used to monitor the Salmonella-free status of 
the birds. 
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The first sampling was done 5 days after the inoculation (in the case of the 
vaccine control and challenge control groups) or 5 days after challenge (in the 
case of the Principal groups). Samplings of that order were repeated weekly until 
the 4th week (Tables 2 and 3). The experiment was performed twice (Experiment 1 
and Experiment 2). 
In Experiment 1 the presence of the challenge SE147 NalR in the liver and 
spleen and its CFU/g in the caecal contents were selectively determined as de-
scribed above in the section ‘In vivo organ invasion and colonisation studies’. In 
Experiment 2, besides the presence of Salmonella in organs, the bacterial counts 
of liver and spleen were also determined as follows: 0.2 g samples of liver and 
spleen were taken aseptically, homogenised and diluted in a 50-fold volume of 
RV broth supplemented with the appropriate antibiotics (Nal, Spe or Cm) in a 
sterile plastic bag, using a Stomacher blender (Seward Stomacher 80, Biomaster). 
Homogenised liver and spleen samples were decimally diluted and dilutions 
plated out on BTB agar containing matching antibiotics for the respective deter-
mination of CFU/g of Salmonella. For assessing Salmonella shedding of chicks 
in the Principal and control groups, cloacal swab samples were taken weekly, 
and incubated in RV broth at 41 °C for 48 h. Subsequently a loopful of culture 
from each selective enrichment RV broth was streaked onto BTB agar plates 
containing the appropriate antibiotics and incubated for further 24 h at 37 °C. 
The Salmonella-free status of the birds was monitored through parallel testing of 
the caecal content of three chicks at each sampling time from a noninfected intact 
control group (ISO 6579:2002). 
Detection of antibodies against Salmonella Enteritidis flagellin by double-
antibody sandwich (DAS) blocking ELISA 
Levels of anti-flagellar antibodies were determined by double-antibody 
sandwich blocking enzyme-linked immunosorbent assay (DAS-ELISA) as de-
scribed by van Zijderveld et al. (1993). For the specific blocking of serum anti-
bodies the monoclonal antibodies 9G3 were used. These were produced and 
tested against S. Enteritidis flagellar antigen H:g,m, and for specific detection of 
these flagellar antibodies in poultry sera by our group (Szmollény et al., 1999). 
Serum inhibitory values > 40% of the absorbance (A450) in wells to which only the 
conjugate was added, were regarded as positive. In these studies sera from 20 birds 
of the vaccine control group 1 (inoculated with parental SE11 only) and 20 birds 
from the vaccine control group 2 [inoculated with nonflagellated-plasmidless 
(fliD–, pSEVΔ) mutant SEΔ155 only] were tested at 4 weeks post inoculation. 
Sera of four uninoculated SPF broiler breeder (Ross 308) chicks were used as 
negative control. 
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Data analysis 
Data from the fibroblast invasion experiments were analysed by Student’s 
t-test. Salmonella isolation (percentage of Salmonella-positive samples from the 
organ invasion and protection experiments) was compared between each group 
by G-test. Data analysis of the second protection experiment (with CFU of Sal-
monella in organs) was made by ANOVA. We used a significance level of P = 
0.05 for all statistical tests. 
 
Results 
In vitro invasiveness of the SE11 mutants: SE2102 (fliD–) and SEΔ155 (fliD–, 
pSEVΔ) 
The mutants of SE11 described above designated as ‘nonmotile’ (SE2102) 
and ‘nonmotile-plasmidless’ (SEΔ155), respectively, have proved to be signifi-
cantly (P < 0.005) less invasive than the wild-type parental strain SE11 in CEF 
cell cultures in vitro. On the other hand, there was no significant difference be-
tween the nonmotile SE2102 and the nonmotile plasmid-cured SEΔ155 (P = 
0.415) mutants in this respect (Fig. 1). 
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Fig. 1. In vitro invasion properties of the wild-type parental S. Enteritidis 11 (SE11), its nonmotile 
(fliD–) mutant SE2102 and its nonmotile-plasmidless (fliD–, pSEVΔ) derivative SEΔ155 in com-
parison with the virulent wild-type S. Enteritidis 147 (SE147) strain in chicken embryo fibroblast 
(CEF) cells. Escherichia coli strain C600 served as negative control. There is no statistically sig-
nificant difference between wild SE strains or between mutant strains. Both wild strains are signifi-
cantly (P < 0.005) more invasive than the mutant strains 
Organ invasion and intestinal colonisation properties of the SE11 mutants 
The nonmotile (fliD–) SE2102, the nonmotile-plasmidless (fliD–, pSEVΔ) 
SEΔ155 mutants and the parental S. Enteritidis 11 strains were tested for liver 
and spleen invasion as well as for caecal colonisation in day-old SPF chicks in 
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two independent oral infection experiments (A and B) using a lower and a higher 
infective dose (Table 1). None of the doses of any of the strains resulted in the 
death of inoculated chicks. Both the SE2102 and the SEΔ155 mutants proved to 
have significantly (P < 0.05) reduced liver and spleen invasiveness as compared 
to the wild-type parental strain SE11. On the other hand, there was no reduction 
in caecal colonisation by these mutants in comparison to the parental strain, and 
there was no statistically significant difference between mutants SE2102 and 
SEΔ155 in terms of organ invasion and caecal colonisation either. The results of 
caecal colonisation and organ invasion for all the test strains proved to be dose 
dependent (Table 1). 
Protection of day old chicks by the nonmotile-plasmidless mutant SEΔ155 
against organ invasion, caecal colonisation and shedding of the virulent  
challenge S. Enteritidis 147 NalR strain 
Oral inoculation of day-old chicks with S. Enteritidis 11 SpeR parental 
strain or its nonmotile-plasmidless (fliD–, pSEVΔ) SEΔ155 mutant and the 2nd 
day challenge with virulent S. Enteritidis 147 NalR were performed in two subse-
quent experiments. Liver and spleen invasion and caecal colonisation as well as 
the results of Salmonella shedding were determined weekly until the 4th week 
after challenge. Combined results of the two experiments (proportions of organs 
and cloacal samples with SE147 challenge strain, and CFU/g of SE147 in 
caecum) are presented in Fig. 2. Detailed numerical results of the two experi-
ments are shown in Table 2 and Table 3, respectively. The data of Experiment 2 
presenting CFU/g of Salmonella in organs indicate that the application of the 
vaccine candidate nonmotile-plasmidless (fliD–, pSEVΔ) mutant SEΔ155 sig-
nificantly (P < 0.05) reduced the counts of SE147 challenge strain in the liver dur-
ing the first two weeks post challenge, and there was a significant reduction (P < 
0.05) of the challenge strain in the spleen for three weeks post challenge. This 
reduction proved to be at least as effective as that induced by the SE11 parental 
strain as there was no significant difference between the parental SE11 and its 
nonmotile-plasmidless (fliD–, pSEVΔ) mutant SEΔ155 (Table 3). Besides, there 
was a significantly (P < 0.01) reduced caecal colonisation in groups Principal 1 
and Principal 2 relative to the challenge control in both experiments (Table 2, 
Table 3 and Fig. 2). Furthermore, a strong reduction (P < 0.01) of cloacal shed-
ding of the challenge strain was clearly demonstrable with no detectable chal-
lenge strain in faecal samples from the third week post infection both in Principal 
group 1 (vaccinated previously with the SE11 parental strain) and in Principal 
group 2 [vaccinated previously with the nonmotile-plasmidless (fliD–, pSEVΔ) 
mutant SEΔ155], as shown in Table 2, Table 3 and Fig. 2. 
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Serological distinction of vaccinated flocks by DAS-ELISA 
In these studies, sera of 20 birds each from the vaccine control groups in-
fected only with the parental SE11 or with the nonmotile-plasmidless (fliD–, 
pSEVΔ) mutant SEΔ155 were compared. The average inhibitory capacity of 
anti-flagellin antibodies detectable in sera of the birds inoculated with the paren-
tal strain SE11 was 48.1% in contrast to the birds inoculated with the mutant 
SEΔ155 (10.8%) (Fig. 3). In the group infected with the parental strain SE11 the 
inhibitory potential of the anti-flagellin antibodies exceeded the 40% threshold in 
12 out of the 20 birds tested. In contrast, no individual serum of the chickens in-
fected with the nonmotile-plasmidless (fliD–, pSEVΔ) mutant SEΔ155 exceeded 
this inhibitory threshold, and the inhibitory values of the four negative control 
sera of intact birds were ≤ 10.0%. The difference in anti-flagellar antibody re-
sponse between the SE11-inoculated and the mutant SEΔ155 inoculated chickens 
was significant (P < 0.001). 
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Fig. 3. Average inhibitory capacity of anti-flagellin antibodies detectable in the sera of 20 birds  
inoculated with SE11 wild-type strain and of 20 birds inoculated with its nonmotile-plasmidless 
(fliD–, pSEVΔ) mutant SEΔ155 four weeks post infection. A significant (P < 0.01) increase was 
detected at 4 weeks post inoculation in SE11-inoculated chickens as compared to those inoculated 
with the nonmotile-plasmidless (fliD–, pSEVΔ) mutant SEΔ155 
 
 
Discussion 
An important requirement for the new generation of live oral vaccines is to 
be distinguishable from field isolates by inducing a different serological host re-
sponse (Barrow and Wallis, 2000). The most straightforward solution to provide 
a negative serological marker for a Salmonella strain is the elimination of flagel-
lae. A nonflagellated S. Enteritidis vaccine candidate strain (ΔguaB, ΔfliC) has 
been produced and proven to be promising in the protection of chicks against 
homologous challenge (Adriaensen et al., 2007). Further fliC– S. Enteritidis vac-
cine candidates have been reported by Methner et al. (2011a) and Matulova et al. 
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(2013). In these studies nonflagellated mutants were produced by Lambda-Red 
recombination mutagenesis (Datsenko and Wanner, 2000). Here we have used a 
nonflagellated (fliD–) mutant with transposon insertion in the flagellar capping 
gene generated by a novel method based on IS30 mediated site-directed 
mutagenesis (Imre et al., 2011). 
Another specific attribute of our nonmotile vaccine candidate mutant 
SEΔ155 is the lack of its serovar-specific virulence plasmid (fliD–, pSEVΔ). 
This is in contrast to the above-mentioned non-motile S. Enteritidis vaccine can-
didates which are not reported to be devoid of pSEV. The role of such plasmids 
in the in vitro and in vivo invasion by Salmonella is less clear. Virulence plas-
mids of certain Salmonella serovars (S. Enteritidis, S. Gallinarum, S. Pullorum, S. 
Typhimurium, S. Choleraesuis, S. Dublin) are known to contribute to the propa-
gation and survival of bacteria in the appropriate host. These plasmids contain 
several genes responsible for virulence-related traits. The most important among 
them is the spv (Salmonella plasmid virulence) region, assisting in bacterial sur-
vival within granulocytes and macrophages. Further important virulence deter-
minants are the pef (plasmid-encoded fimbriae) operon, mediating adhesion to 
the intestinal cells, and the rck gene (resistance to complement killing) (Rychlik 
et al., 2006; Imre et al., 2007). The function of these genes may be important in 
the infection process, and in the long-time persistence of Salmonella in some 
animal hosts and in humans. Earlier Barrow and Lowell (1989) found that se-
rovar-specific virulence plasmids of S. Typhimurium, S. Gallinarum and S. Pul-
lorum are not essential for Vero cell invasion. The results of Halavatkar and Bar-
row (1993) and of Martin et al. (1996) indicate that such virulence plasmids of S. 
Enteritidis are important for virulence in mice, but not in chickens. These find-
ings are in line with the in vivo results of Gulig and Curtiss (1987) and of Imre et 
al. (2007). However, based on the recent evidences and the potential public 
health aspects the elimination of the serovar-specific virulence plasmid should be 
regarded as an advantage for the development and registration of live oral Sal-
monella vaccines (Martin et al., 1996; Barrow and Wallis, 2000). 
Invasion and virulence tests carried out on nonmotile (fliD–) and on non-
motile plasmid-cured (fliD–, pSEVΔ) mutants of S. Enteritidis 11 strain showed 
that the above mutants were equally much less invasive in a CEF model in vitro 
than the wild-type parental strain, and proved to have diminished organ inva-
siveness in day-old chickens as well. Our results are in harmony with the in vitro 
invasion results of previous publications comparing wild-type strains and non-
flagellated (fliC-deleted) mutants of different Salmonella serovars, indicating that 
flagellae are necessary for the proper invasion of S. Enteritidis into human Caco-
2 and Hep-2 tumour cells (Van Asten et al., 2000; La Ragione et al., 2003), but 
differ somewhat from those obtained on fliC-deleted mutants of different strains 
of S. Enteritidis (Adriaensen et al., 2007; Methner et al., 2011b). Adriaensen et 
al. (2007) found that the fliCΔ mutant of their wild-type S. Enteritidis 76Sa88 
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showed less reduced invasion of human (T84) or chicken intestinal epithelial 
cells. Unfortunately, these authors did not compare their double-deletion mutant 
(ΔguaB ΔfliC) in day-old chicks to either the ΔfliC single mutant or to the wild 
parent strain. Therefore, our and their results could not be directly compared. In 
general, it must be noted that not all kinds of ‘nonflagellated’ mutants of all S. 
Enteritidis strains may lose their invasiveness. The fliCΔ mutant of S.E147 of 
Methner et al. (2011b) did not prove to be sufficiently attenuated in chicks. As a 
further example, flhD deletion mutants of the SE-HCD strain remained invasive 
in spite of their nonflagellar phenotype (Parker and Guard-Petter, 2001). This 
might be due to the temporary suppression of Class I regulators of flagellin bio-
synthesis, in contrast to ∆fliC flagellin gene mutants of the same strain that be-
came significantly and permanently nonflagellated and less invasive when tested 
in orally inoculated day-old chicks. In our studies we partly confirmed and ex-
tended the above observations by proving the significantly reduced invasiveness 
of the S. Enteritidis nonflagellated fliD– mutants of SE11 in vitro and in vivo. 
Our results also suggest that flagellae per se may act as a virulence factor. At the 
same time, here we confirm that the flagellar protein FliD itself is not required 
for the efficient vaccination of chickens. Although there are several data support-
ing the role of flagellae in cellular and humoral immune responses to Salmonella 
(Salazar-Gonzalez and McSorley, 2005), the results of Kodama and Matsui (2004) 
and Adriaensen et al. (2007) also suggest that Salmonella flagellin is not a major 
protective antigen in mice. As stated above, our results confirm and extend these 
observations on the lack of a major protective role of S. Enteritidis flagellin 
against Salmonella infection in chicks. In spite of decreased virulence, the oral 
vaccination of day-old chicks with this live attenuated (fliD–, pSEVΔ) mutant 
SEΔ155 resulted in pronounced early protective activity against organ invasion 
and caecal colonisation by, and against shedding of, the highly virulent S. Enteri-
tidis 147 challenge strain, as demonstrated during the first four weeks of life. In 
fact, the level of protection conferred by this fliD–, pSEV∆ mutant proved to be 
very similar to that induced by the wild-type parental strain. By this, we provided 
data for the first time about a virulence plasmid cured nonflagellated mutant of S. 
Enteritidis to serve as a basis for the development of a negatively markered po-
tential live oral vaccine against virulent S. Enteritidis in chicken. 
One explanation for this remarkable early protection is presumably the 
colonisation inhibition or competitive exclusion between bacteria of the same 
Salmonella serovar (Barrow et al., 1987; Nógrády et al., 2003; Methner et al., 
2011a). Although several commercial and experimental live attenuated Salmo-
nella vaccines with certain metabolic mutations have been reported to induce 
protection against organ invasion and immune response after a single oral appli-
cation, most of them did not seem to be able to inhibit intestinal colonisation of 
the challenge Salmonella organisms (Van Immerseel et al., 2002; Barrow, 2007). 
Some of them did exert a modest inhibition of colonisation against homologous 
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challenge (Methner et al., 1997). Live attenuated Salmonella vaccines produced 
by targeted mutagenesis have also been extensively tested in several animal spe-
cies, and it is known that such strains more readily promote a long-lasting cell-
mediated immunity than the killed vaccines (Zhang-Barber et al., 1999; Van 
Immerseel et al., 2005; Barrow, 2007; Pasquali et al., 2008). Recently a nonflag-
ellated (ΔguaB, ΔfliC) mutant produced by Adriaensen et al. (2007), and the non-
flagellated (ΔphoP, ΔfliC) mutant of S. Enteritidis produced by Methner et al. 
(2011b) have been demonstrated to confer sufficient protection against organ in-
vasion by a virulent S. Enteritidis challenge strain, but either no reduction or only 
a weak reduction of colonisation was proven, respectively. Besides, neither of 
these two papers reported about cloacal shedding of the challenge S. Enteritidis 
strain. Here we found significantly (P < 0.01) decreased cloacal shedding com-
pared to the challenge control for the first two weeks and it was completely 
eliminated for the 3rd and 4th weeks after challenge. In short, in our studies the 
nonmotile virulence-plasmid cured (fliD–, pSEVΔ) mutant did not only provide 
protection against organ invasion but also effectively reduced caecal colonisation 
and cloacal shedding of the highly virulent S. Enteritidis. In this respect our re-
sults were similar to those of Matulova et al. (2013). 
In this study we also compared the production of anti-flagellar antibodies 
in chicks inoculated with the nonmotile-plasmidless (fliD–, pSEV∆) mutant 
SEΔ155 with that found in chicks inoculated with the motile parental strain 
SE11. A significant (P < 0.01) increase at 4 weeks post inoculation was detected 
in SE11-inoculated chickens as compared to those inoculated with the nonmo-
tile-plasmidless (fliD–, pSEVΔ) mutant SEΔ155. The results indicated that the 
significant difference in the titre of anti-flagellin antibodies can be used as a 
negative marker for the differentiation of vaccinated groups from those infected 
with the wild-type strain, similarly as has been described for the S. Enteritidis 
fliC– mutant very recently (Methner et al., 2011b; Matulova et al., 2013). 
In summary, the negatively markered, nonmotile-plasmidless (fliD–, pSEV∆) 
mutant of a wild Salmonella Enteritidis strain constructed with the further aim of 
serving as a live, oral chicken vaccine candidate, has been tested for residual viru-
lence in the in vitro (cell culture) and in vivo (day-old chick oral infection) models 
and proved to be sufficiently attenuated without reduced intestinal colonisation ca-
pacity. Early protective activity of the nonmotile-plasmidless mutant SEΔ155 against 
organ invasion and caecal colonisation as well as against long-term shedding of 
the highly virulent S. Enteritidis 147 strain was demonstrable during the first four 
weeks of life. The serological response of chicks inoculated with the nonmotile-
plasmidless mutant SEΔ155 could be differentiated from that of chicks inocu-
lated with the wild-type strain of S. Enteritidis. Thus, our studies have shown for 
the first time that the nonmotile, virulence-plasmid cured (fliD–, pSEV∆) mutant 
SEΔ155 of S. Enteritidis studied here, can be used as a negatively markered live 
oral vaccine candidate against highly virulent strain of S. Enteritidis in chickens. 
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